Kidney cancer trials in China

In China 116 Also abroad 485

116 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
Where
Shijiazhuang
Age
18 years and over
People
48
Run by
Hebei Medical University Fourth Hospital
See details and how to joinNCT07744932
Phase 2Taking people
Gut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
Where
Nanjing
Age
18 years to 90 years
People
33
Run by
Jinling Hospital, China
See details and how to joinNCT07611825
Phase 2Not yet taking people in China
A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
Where
Nanjing
Age
18 years to 75 years
People
54
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07741617
No phaseTaking people
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations
Where
Shanghai
Age
18 years and over
People
400
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT04113486
Phase 2Not yet taking people in China
Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
Where
Chengdu
Age
14 years and over
People
66
Run by
West China Hospital
See details and how to joinNCT07715565
Phase 1Not yet taking people in China
Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
Where
Beijing
Age
18 years and over
People
8
Run by
Jian Lin
See details and how to joinNCT07686744
Phase 1Taking people
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Where
Changchun, Changsha, Fuzhou, Guangzhou, Hangzhou, Harbin, Kunming, Luoyang, Nanchang, Shanghai, Shenyang, Wuhan
Age
18 years and over
People
214
Run by
Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06839105
Phase 1Taking people
To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
Where
Shanghai
Age
18 years to 70 years
People
18
Run by
Hrain Biotechnology Co., Ltd.
See details and how to joinNCT07647744
Phase 1Taking people
A Study of DEG6498 in Participants With Solid Tumors
Where
Beijing, Guangzhou
Age
18 years and over
People
100
Run by
Degron Therapeutics Co.
See details and how to joinNCT07244835
No phaseTaking people
Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)
Where
Tianjin
Age
18 years and over
People
220
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07321197
Early phase 1Taking people
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Chinese PLA General Hospital
See details and how to joinNCT07645690
No phaseTaking people
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
Where
Tianjin
Age
18 years and over
People
110
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07657325
Phase 1/2Not yet taking people in China
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Where
Beijing
Age
18 years to 75 years
People
40
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07630363
Phase 2Not yet taking people in China
Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
Where
Beijing, Changchun, Changsha, Hangzhou, Kunming, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
Age
18 years to 75 years
People
144
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07627464
Phase 2Taking people
68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision
Where
Beijing
Age
18 years and over
People
70
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06949215
Early phase 1Taking people
Clinical Application of CAIX-Targeted PET Imaging in Tumors
Where
Beijing
Age
18 years to 75 years
People
3
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07590310
No phaseTaking people
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University First Hospital
See details and how to joinNCT07557225
Phase 1Taking people
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Where
Guangzhou
Age
2 years to 18 years
People
51
Run by
Sun Yat-sen University
See details and how to joinNCT07584499
Phase 2Taking people
CD70-targeted immunoPET Imaging of Malignant Cancers
Where
Shanghai
Age
18 years to 80 years
People
300
Run by
RenJi Hospital
See details and how to joinNCT06852638
Phase 2Taking people
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
Where
Nanjing
Age
18 years to 80 years
People
75
Run by
Jinling Hospital, China
See details and how to joinNCT07571551
Phase 1/2Taking people
Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
Where
Shenzhen
Age
18 years and over
People
36
Run by
Beijing Biotech
See details and how to joinNCT07551349
No phaseTaking people
CAIX PET/ CT Guided Radiation Therapy in CcRCC.
Where
Beijing
Age
18 years and over
People
70
Run by
Peking University First Hospital
See details and how to joinNCT07540260
Phase 1Taking people
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
Where
Wuhan
Age
18 years and over
People
12
Run by
Grit Biotechnology
See details and how to joinNCT06819293
No phaseTaking people
Validation of RCC Predicting Model With Emulated-target Trial
Where
Beijing
Age
18 years to 80 years
People
4,700
Run by
Peking University Third Hospital
See details and how to joinNCT07117227
Phase 1Not yet taking people in China
UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma
Where
Zhengzhou
Age
18 years to 75 years
People
21
Run by
UTC Therapeutics Inc.
See details and how to joinNCT07500805